Eye drops for dry eyes in Sjögren's syndrome
Part of Bones, joints & muscles, Eyes & vision, Immune system & allergy, Mouth & dental, Skin clinical trials.
This trial tests an experimental eye drop made from stem cells to see if it can help with the severe dry eye symptoms of Sjögren's syndrome. It might be an option if standard treatments like artificial tears haven't worked well for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have Sjögren's syndrome with dry eye symptoms that haven't improved after at least 3 months of standard care, like artificial tears or steroid eye drops.
- Your other Sjögren's symptoms (like fatigue or joint pain) are stable.
- You are willing to use reliable birth control if you or your partner could become pregnant, during the study and for several months after.
- You have no other major eye diseases (like glaucoma, uveitis, or eye injuries) and have not had eye surgery in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase trial tests whether a new treatment using exosomes (tiny natural particles) given as eye drops or injections can help people with Sjögren's syndrome who have severe dry eyes that haven't responded to usual treatments. The goal is to see if it's safe and to get early hints of whether it relieves eye symptoms.
This trial tests a new eye drop made from a natural protein (rhPRG4) to see if it safely and effectively relieves dry eye symptoms in people with Sjögren's syndrome. You'll be randomly assigned to receive the study drop or a placebo (inactive) drop for several weeks.
This trial tests if using special eye drops (cyclosporine) along with tiny plugs placed in the tear ducts can improve dry eye symptoms in people with Sjögren's syndrome. The goal is to see if this combination works better than the drops alone.
This study tests a new eye drop called CSB-001 for people with limbal stem cell deficiency (LSCD), a condition that damages the cornea. The goal is to see if the drops can help improve the health of the cornea and reduce inflammation.
This study looks at tiny particles called exosomes in tears to find new ways to diagnose or treat Sjogren's syndrome and dry eye disease. It may help people with these conditions by learning more about what causes them.
This study tests whether an eye drop containing infliximab (a drug that blocks inflammation) can safely reduce severe dry eye symptoms caused by Sjögren's syndrome, and it also looks at how well the drug works.
Hear when a new Sjögren's Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.